Frank Barnhart

2.0k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Frank Barnhart is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Frank Barnhart has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 1 paper in Molecular Biology. Recurrent topics in Frank Barnhart's work include Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Asthma and respiratory diseases (6 papers) and Respiratory Support and Mechanisms (5 papers). Frank Barnhart is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Asthma and respiratory diseases (6 papers) and Respiratory Support and Mechanisms (5 papers). Frank Barnhart collaborates with scholars based in United States, United Kingdom and Denmark. Frank Barnhart's co-authors include Fernando J. Martínez, Mark T. Dransfield, Robert A. Wise, Sally Kilbride, Peter Lange, Noushin Brealey, Dave Singh, Christine Jones, Jean Brooks and Maggie Tabberer and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and Drugs.

In The Last Decade

Frank Barnhart

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

2018 758 citations David A. Lipson, Frank Barnhart et al. New England Journal of Medicine profile →

Peers

Frank Barnhart

PRM

PHYSI

EMS

EPIDE

MB

Noushin Brealey United Kingdom

Sally Kilbride United States

Benjamin Hartley United Kingdom

Steven Pascoe United Kingdom

Earl St. Rose United States

Lucy Frith United Kingdom

Shireen Mirza United States

Netsanet A. Negewo Australia

A. Dixmier France

Michael T. Zvarich United Kingdom

Noushin Brealey United Kingdom

Frank Barnhart

1.3k ×1.0

PRM

964 ×1.1

PHYSI

62 ×0.9

EMS

44 ×0.8

EPIDE

24 ×0.5

MB

Citations per year, relative to Frank Barnhart Frank Barnhart (= 1×) peers Noushin Brealey

Countries citing papers authored by Frank Barnhart

Since Specialization

Citations

This map shows the geographic impact of Frank Barnhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Barnhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Barnhart more than expected).

Fields of papers citing papers by Frank Barnhart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Barnhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Barnhart. The network helps show where Frank Barnhart may publish in the future.

Co-authorship network of co-authors of Frank Barnhart

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Barnhart. A scholar is included among the top collaborators of Frank Barnhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Barnhart. Frank Barnhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Barnhart, Frank, Courtney Crim, Noushin Brealey, et al.. (2019). Comparison of LAMA/LABA vs. ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial. Pneumologie. 1 indexed citations

2.

Lipson, David A., Frank Barnhart, Noushin Brealey, et al.. (2018). Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. New England Journal of Medicine. 378(18). 1671–1680. 758 indexed citations breakdown →

3.

Lipson, David A., Frank Barnhart, Courtney Crim, et al.. (2018). Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial. PA4385–PA4385. 1 indexed citations

4.

Lipson, David A., Frank Barnhart, Courtney Crim, et al.. (2018). Exacerbation outcomes with LAMA/LABA and ICS/LABA in high risk COPD patients in the IMPACT trial. PA4384–PA4384. 4 indexed citations

5.

Singh, Dave, Frank Barnhart, Noushin Brealey, et al.. (2018). FF/UMEC/VI versus FF/VI and UMEC/VI in the ELLIPTA device in patients with COPD: Subgroup analyses from the IMPACT trial. PA4383–PA4383. 1 indexed citations

6.

Crim, Courtney, Mark T. Dransfield, Jean Bourbeau, et al.. (2014). Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD. Annals of the American Thoracic Society. 12(1). 27–34. 112 indexed citations

7.

Dransfield, Mark T., Jean Bourbeau, Paul Jones, et al.. (2013). Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. The Lancet Respiratory Medicine. 1(3). 210–223. 246 indexed citations

8.

Hanania, Nicola A., Gregory Feldman, Jae-Jeong Shim, et al.. (2012). The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD. CHEST Journal. 142(1). 119–127. 83 indexed citations

9.

Calverley, Peter, Mark T. Dransfield, Jean Bourbeau, et al.. (2012). Safety of fluticasone furoate (FF), an inhaled corticosteroid in combination with vilanterol (VI), a long-acting beta agonist in management of COPD exacerbations. 40. 2113.

10.

Rennard, Stephen I., Katharine Knobil, Klaus F. Rabe, et al.. (2008). The Efficacy and Safety of Cilomilast in COPD. Drugs. 68(Supplement 2). 3–57. 82 indexed citations

11.

Ferguson, Gary T., et al.. (2003). Cardiovascular Safety of Cilomilast in Patients With Chronic Obstructive Pulmonary Disease (COPD. CHEST Journal. 124(4). 171S–171S. 5 indexed citations

12.

Reisner, Colin, et al.. (2003). Cilomilast Reduces Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD. CHEST Journal. 124(4). 127S–127S. 5 indexed citations

13.

Borker, Rohit, et al.. (2003). Effect of Cilomilast on Chronic Obstructive Pulmonary Disease (COPD) Patients With Impaired Quality of Life (QOL. CHEST Journal. 124(4). 129S–129S. 5 indexed citations

14.

Lumry, William R., et al.. (2001). Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma. Annals of Allergy Asthma & Immunology. 86(3). 297–303. 25 indexed citations

15.

Shapiro, Gail, et al.. (2000). Clinical Comparability of Ventolin Formulated With Hydrofluoroalkane or Conventional Chlorofluorocarbon Propellants in Children With Asthma. Archives of Pediatrics and Adolescent Medicine. 154(12). 1219–1219. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact